MALVERN, Pa., Dec. 2, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today the launch of its ADRENALIN® (epinephrine in 0.9% sodium chloride injection) ready-to-use premixed bag, the first ...
A ready-to-use premixed formulation of Adrenalin ® (epinephrine in 0.9% sodium chloride injection) has been made available by Endo, Inc. Adrenalin is a non-selective alpha and beta adrenergic agonist ...
Endo's products are the first FDA-approved and currently the only commercially available manufacturer-prepared epinephrine premixed intravenous (IV) bag "Hospital pharmacists and healthcare providers ...
Epinephrine nasal solutions from BPI Labs and Endo USA should not be used, according to the FDA. Similarities between the packaging for certain intranasal and intravenous epinephrine products may ...
Please provide your email address to receive an email when new articles are posted on . Epinephrine autoinjectors may have little effect on surviving anaphylaxis events. Research is needed in ...
MALVERN, Pa., Sept. 23, 2025 /PRNewswire/ -- Endo, a wholly-owned subsidiary of Mallinckrodt plc, announced today the launch of ADRENALIN ® (epinephrine in 0.9% sodium chloride injection) premixed IV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results